121 related articles for article (PubMed ID: 28508843)
1. Acoustic analysis of voice in nonlaryngeal head and neck cancer patients post chemoradiotherapy.
Radhakrishna N; Yamini BK; Kadam AS; Shivashankar N; Vishwanathan C; Javarappa R
J Cancer Res Ther; 2017; 13(1):113-117. PubMed ID: 28508843
[TBL] [Abstract][Full Text] [Related]
2. Prospective pilot study of consolidation chemotherapy with docetaxel and cisplatin after concurrent chemoradiotherapy for advanced head and neck cancer.
Lee KC; Lee SH; Lee Y; Park SH; Park J; Cho EK; Shin DB; Lee JH; Kim DY; Kim ST
Int J Radiat Oncol Biol Phys; 2008 May; 71(1):187-91. PubMed ID: 17996392
[TBL] [Abstract][Full Text] [Related]
3. Systematic Review and Meta-analysis of Conventionally Fractionated Concurrent Chemoradiotherapy versus Altered Fractionation Radiotherapy Alone in the Definitive Management of Locoregionally Advanced Head and Neck Squamous Cell Carcinoma.
Gupta T; Kannan S; Ghosh-Laskar S; Agarwal JP
Clin Oncol (R Coll Radiol); 2016 Jan; 28(1):50-61. PubMed ID: 26454839
[TBL] [Abstract][Full Text] [Related]
4. Functional organ preservation in patients with locoregionally advanced head and neck squamous cell carcinoma treated by platinum-based multidrug induction chemotherapy and concurrent chemoradiotherapy.
Boscolo-Rizzo P; Gava A; Marchiori C; Baggio V; Da Mosto MC
Ann Oncol; 2011 Aug; 22(8):1894-901. PubMed ID: 21273343
[TBL] [Abstract][Full Text] [Related]
5. Locally advanced head and neck cancer treated with accelerated radiotherapy, the hypoxic modifier nimorazole and weekly cisplatin. Results from the DAHANCA 18 phase II study.
Bentzen J; Toustrup K; Eriksen JG; Primdahl H; Andersen LJ; Overgaard J
Acta Oncol; 2015 Jul; 54(7):1001-7. PubMed ID: 25629651
[TBL] [Abstract][Full Text] [Related]
6. Concurrent chemoradiotherapy with low-dose cisplatin plus 5-fluorouracil for the treatment of patients with unresectable head and neck cancer.
Kohno N; Kitahara S; Tamura E; Tanabe T
Oncology; 2002; 63(3):226-31. PubMed ID: 12381901
[TBL] [Abstract][Full Text] [Related]
7. Pre- and posttreatment voice and speech outcomes in patients with advanced head and neck cancer treated with chemoradiotherapy: expert listeners' and patient's perception.
van der Molen L; van Rossum MA; Jacobi I; van Son RJ; Smeele LE; Rasch CR; Hilgers FJ
J Voice; 2012 Sep; 26(5):664.e25-33. PubMed ID: 22209059
[TBL] [Abstract][Full Text] [Related]
8. Randomized trial comparing surgery and adjuvant radiotherapy versus concurrent chemoradiotherapy in patients with advanced, nonmetastatic squamous cell carcinoma of the head and neck: 10-year update and subset analysis.
Iyer NG; Tan DS; Tan VK; Wang W; Hwang J; Tan NC; Sivanandan R; Tan HK; Lim WT; Ang MK; Wee J; Soo KC; Tan EH
Cancer; 2015 May; 121(10):1599-607. PubMed ID: 25639864
[TBL] [Abstract][Full Text] [Related]
9. Assessment of Voice Outcomes Post Chemo-Radiotherapy in Non-Laryngeal Head & Neck Cancers Using Electroglottography and Voice Symptom Scale (VoiSS) Questionnaire.
Radhakrishna N; Yamini BK; Sadashiv Kadam A; Shivashankar N; Vishwanathan C; Javarappa R
Gulf J Oncolog; 2022 Jan; 1(38):47-52. PubMed ID: 35156644
[TBL] [Abstract][Full Text] [Related]
10. Randomized controlled phase II comparison study of concurrent chemoradiotherapy with docetaxel, cisplatin, and 5-fluorouracil versus CCRT with cisplatin, 5-fluorouracil, methotrexate and leucovorin in patients with locally advanced squamous cell carcinoma of the head and neck.
Tsukuda M; Ishitoya J; Matsuda H; Horiuchi C; Taguchi T; Takahashi M; Nishimura G; Kawakami M; Watanabe M; Niho T; Kawano T; Ikeda Y; Sakuma Y; Shiono O; Komatsu M
Cancer Chemother Pharmacol; 2010 Sep; 66(4):729-36. PubMed ID: 20033810
[TBL] [Abstract][Full Text] [Related]
11. Taxane, platinum and 5-FU prior to chemoradiotherapy benefits patients with stage IV neck node-positive head and neck cancer and a good performance status.
Lowe NM; Bernstein JM; Mais K; Garcez K; Lee LW; Sykes A; Thomson DJ; Homer JJ; West CM; Slevin NJ
J Cancer Res Clin Oncol; 2018 Feb; 144(2):389-401. PubMed ID: 29222650
[TBL] [Abstract][Full Text] [Related]
12. Treatment results and prognostic factors for advanced squamous cell carcinoma of the hypopharynx treated with concurrent chemoradiotherapy.
Taguchi T; Nishimura G; Takahashi M; Komatsu M; Sano D; Sakuma N; Yabuki K; Arai Y; Takahashi H; Hata M; Koike I; Oridate N
Cancer Chemother Pharmacol; 2014 Jun; 73(6):1147-54. PubMed ID: 24658628
[TBL] [Abstract][Full Text] [Related]
13. [SIB-IMRT radiotherapy given concomitantly with cisplatin for locally advanced squamous cell head and neck cancer (SCHNC). Evaluation of the early results and toxicity].
Kiprian D; Jarząbski A; Pawłowska B; Michalski W; Kawecki A
Otolaryngol Pol; 2011 Sep; 65(5 Suppl):117-25. PubMed ID: 22000261
[TBL] [Abstract][Full Text] [Related]
14. Concomitant adjuvant chemoradiotherapy with weekly low-dose cisplatin for high-risk squamous cell carcinoma of the head and neck: a phase II prospective trial.
Rampino M; Ricardi U; Munoz F; Reali A; Barone C; Musu AR; Balcet V; Franco P; Grillo R; Bustreo S; Pecorari G; Cavalot A; Garzino Demo P; Ciuffreda L; Ragona R; Schena M
Clin Oncol (R Coll Radiol); 2011 Mar; 23(2):134-40. PubMed ID: 21030225
[TBL] [Abstract][Full Text] [Related]
15. Concurrent Chemoradiotherapy With Docetaxel, Cisplatin, and 5-Fluorouracil for T3 N0 Glottic Carcinoma Without Vocal Cord Fixation.
Toya R; Watakabe T; Murakami D; Matsuyama T; Saito T; Fukugawa Y; Nishimoto K; Orita Y; Oya N
Anticancer Res; 2022 Jan; 42(1):205-209. PubMed ID: 34969726
[TBL] [Abstract][Full Text] [Related]
16. Usefulness of interim FDG-PET after induction chemotherapy in patients with locally advanced squamous cell carcinoma of the head and neck receiving sequential induction chemotherapy followed by concurrent chemoradiotherapy.
Yoon DH; Cho Y; Kim SY; Nam SY; Choi SH; Roh JL; Lee SW; Song SY; Lee JH; Kim JS; Cho KJ; Kim SB
Int J Radiat Oncol Biol Phys; 2011 Sep; 81(1):118-25. PubMed ID: 20675065
[TBL] [Abstract][Full Text] [Related]
17. Promising long-term results with attenuated adverse effects by methotrexate-containing sequential chemoradiation therapy in locally advanced head and neck squamous cell carcinoma.
Tsai TL; Chu PY; Tai SK; Wang YF; Yang MH; Wang LW; Lirng JF; Chang SY
Jpn J Clin Oncol; 2011 Oct; 41(10):1182-93. PubMed ID: 21862506
[TBL] [Abstract][Full Text] [Related]
18. Does primary tumour volumetry performed early in the course of definitive concomitant chemoradiotherapy for head and neck squamous cell carcinoma improve prediction of primary site outcome?
Bhatia KS; King AD; Yu KH; Vlantis AC; Tse GM; Mo FK; Ahuja AT
Br J Radiol; 2010 Nov; 83(995):964-70. PubMed ID: 20965907
[TBL] [Abstract][Full Text] [Related]
19. Acoustic analysis after radiotherapy in T1 vocal cord carcinoma: a new approach to the analysis of voice quality.
Rovirosa A; Martínez-Celdrán E; Ortega A; Ascaso C; Abellana R; Velasco M; Bonet M; Herrera C; Casas F; Francisco RM; Arenas M; Hernández V; Sánchez-Reyes A; León C; Traserra J; Biete A
Int J Radiat Oncol Biol Phys; 2000 Apr; 47(1):73-9. PubMed ID: 10758307
[TBL] [Abstract][Full Text] [Related]
20. Acoustic voice analysis in different phonetic contexts after larynx radiotherapy for T1 vocal cord carcinoma.
Rovirosa A; Ascaso C; Abellana R; Martínez-Celdrán E; Ortega A; Velasco M; Bonet M; Herrero T; Arenas M; Biete A
Clin Transl Oncol; 2008 Mar; 10(3):168-74. PubMed ID: 18321820
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
